Mapping Disease-Causing Kidney Cell States to Identify Actionable Pathways & Generate More Precise Therapeutic Targets

11:00 am - Wednesday 17th March 2027

  • Characterizing the cell populations driving initiation and progression across CKD stages
  • Linking dysregulated cell states with molecular pathways and disease phenotype
  • Selecting targets according to both biological relevance and therapeutic tractability

Speakers:

Senior Director - Discovery Research , Kidney Physiologist
Eli Lilly & Co.